Latest Technology News

Brambles Limited reported a 10% rise in underlying profit for FY25, driven by operational efficiencies and digital initiatives, while announcing a US$400 million share buy-back for FY26. The company’s transformation program underpins a confident outlook despite macroeconomic headwinds.

VEEM Limited’s FY25 results reveal a challenging year with revenue down 15%, yet a strong second half turnaround driven by cost cuts and efficiency gains. The company also secured a significant $65 million contract extension and new supplier status for a major US submarine program.

VEEM Ltd posted a 15% revenue decline and a 57% net profit drop for FY25, reflecting cyclical defence contract impacts. The company secured a $65 million ASC contract extension and continues investing in R&D and automation to drive future growth.

Golden Deeps Ltd has reported exceptional high-grade copper, silver, zinc, lead, and germanium results from surface sampling at its Graceland Prospect in Namibia, doubling the mineralised strike length and setting the stage for targeted drilling.

Everest Metals Corporation reveals significant progress in its gold projects and leads the development of Australia’s first rubidium industry, positioning itself at the forefront of critical minerals innovation.

Octava Minerals reports impressive initial bioleaching recoveries of critical rare earth elements and lithium from its Byro Project, highlighting a promising, low-cost extraction pathway.

Athena Resources has produced a 10kg sample of ultra-high-grade magnetite concentrate grading 70.55% iron from its Byro Magnetite Project, positioning the company at the forefront of green steel feedstock supply.

Super Retail Group reported a solid 4.5% sales increase in FY25, driven by network growth and new loyalty initiatives, while navigating margin pressures and investing heavily in omni-channel capabilities.

Heartland Group Holdings Limited reported an underlying NPAT of NZD 46.9 million for FY2025, meeting guidance, while setting ambitious growth and efficiency targets for FY2026.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.

Harmoney has delivered a robust FY25 performance, exceeding its upgraded profit guidance with strong loan book growth and improved efficiency. The fintech lender projects a remarkable 111% increase in cash NPAT for FY26, driven by its AI-powered Stellare 2.0 platform and strategic expansion plans.